NEWS
AMERISOURCEBERGEN BECOMES CENCORA
Cencora has announced the completion of its name and stock ticker change from AmerisourceBergen Corporation , marking the latest stage of the company ’ s evolution as a leader in global pharmaceutical services .
Under the new name , Cencora , the company unifies its 46,000 employees – across several global business segments – under one identity , propelled by a bold vision and purpose-driven approach to creating healthier futures .
The new name underscores Cencora ’ s experience and vision when it comes to connecting manufacturers , providers , pharmacies and patients , and ensuring the consistent , reliable flow of treatments to those who need them at a time of growing complexity .
" This is a significant and exciting milestone for Cencora . Our new name is a reminder of our customers , their patients and our team members who are at the centre of everything we do ,” said Steven H . Collis , Chairman , President and Chief Executive Officer of Cencora .
“ It represents the healthier futures we strive for serving as a trusted industry partner that prioritises innovation , advocates for patient access and advances strategic partnerships across the global pharmaceutical value chain .”
HONEYNAPS RECEIVES FDA APPROVAL FOR AI SLEEP DISORDER DIAGNOSIS SOFTWARE
HoneyNaps , the AI-based sleep disorder diagnosis software company , has announced that its SOMNUM AI sleep disease analysis algorithm has been approved by the US Food and Drug Administration ( FDA ).
The FDA has granted only two approvals for sleep disease diagnosis solutions by US companies and HoneyNaps is the first Korean company to receive this status and identify their
FDA approval as a demonstration of their technology ' s capabilities .
Sleep biosignals tend to include electroencephalograms , electrooculograms , chin and leg electromyograms , electrocardiograms , respiratory airflow and effort , oxygen saturation , posture and snoring , and these are monitored continuously during sleep for assessing sleep status and sleep disorder diagnosis via polysomnography .
HoneyNaps ' SOMNUM ,' transcends conventional video image reading systems for biosignals .
It leverages Deep Learning-based AI to perform real-time analysis of vast volumes of multi-channel / time series biosignals , setting a new standard for accuracy and transparency in the field . SOMNUM ' s development is underpinned by the pioneering eXplainable Medical AI ( XAI ) technology .
Tae Kyoung Ha , General Representative Director at HoneyNaps , said : " The FDA has recently strengthened its review of AI-based medical devices , and we passed the review in three years by conducting clinical trials with 400 subjects including US citizens directly , rather than through an agency , from the validation stage .”
10 www . intelligenthealth . tech